PRIMARY STUDY
Regional Changes in the Type 1 Cannabinoid Receptor Are Associated With Cognitive Dysfunction in Parkinson's Disease
Key Findings: PET scan of participating Parkinson's patients showed decreased CB1 receptor sites in portions of the brain strongly correlated with ill-effects in executive functioning, episodic memory, and visuospatial functioning.
Type of Study: Meta-analysis
Study Sample Size: 38
Study Result: Inconclusive
Cannabinoids Studied: Not Applicable
Phytocannabinoid Source: Not Applicable
Form of Administration: Not Applicable
Receptors Studied: CB1
Study Location(s): Belgium
Year of Pub: 2019
Link to study